🇺🇸 FDA
Patent

US 8188294

Process for preparing biphenyl imidazole compounds

granted A61PA61P29/00A61P43/00

Quick answer

US patent 8188294 (Process for preparing biphenyl imidazole compounds) held by Theravance, Inc. expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P29/00, A61P43/00, A61P9/12